Yilei Mao
- Oncology top 2%
- Molecular Biology top 10%
- Surgery top 5%
- Hepatology top 1%
- Epidemiology top 5%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (45 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (39 papers)Liver Disease Diagnosis and Treatment (28 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yilei Mao
203 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 1.2k
- Molecular Biology 1.1k
- Surgery 989
- Hepatology 937
- Epidemiology 838
Countries citing papers authored by Yilei Mao
This map shows the geographic impact of Yilei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilei Mao more than expected).
Fields of papers citing papers by Yilei Mao
This network shows the impact of papers produced by Yilei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilei Mao. The network helps show where Yilei Mao may publish in the future.
Co-authorship network of co-authors of Yilei Mao
This figure shows the co-authorship network connecting the top 25 collaborators of Yilei Mao. A scholar is included among the top collaborators of Yilei Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilei Mao. Yilei Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 24 | |
| 7 | 0 | |
| 8 | 5 | |
| 9 | 13 | |
| 10 | 2 | |
| 11 | 5 | |
| 12 | 22 | |
| 13 | 6 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 5 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 44 |
About Yilei Mao
Yilei Mao is a scholar working on Hepatology, Oncology and Cancer Research, having authored 210 papers that have together received 4.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (39 papers) and Liver Disease Diagnosis and Treatment (28 papers). The work is most often cited by research in Hepatology (937 citations), Cancer Research (700 citations) and Oncology (1.2k citations). Yilei Mao has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Huayu Yang, Xinting Sang, Haitao Zhao, Shouxian Zhong, Shunda Du, Lejia Sun, Xin Lu, Gang Xu, J. Michael Millis and Hongbing Zhang. Their work appears in journals such as The Lancet, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.